Clinical trials
Phase 4 Atrial Fibrillation trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 6 |
| 2013 | 5 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 5 |
| 2021 | 7 |
| 2023 | 3 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Terminated | 13 |
| Withdrawn | 7 |
| Recruiting | 5 |
| Unknown status | 5 |
| Active, not recruiting | 4 |
| Not yet recruiting | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biosense Webster, Inc. | 3 |
| Boehringer Ingelheim | 3 |
| Indiana University | 3 |
| Mayo Clinic | 3 |
| Population Health Research Institute | 3 |
| University of Michigan | 3 |
| Creighton University | 2 |
| Electrophysiology Research Foundation | 2 |
| Sanofi | 2 |
| The Cleveland Clinic | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atrial Fibrillation | 80 |
| Atrial Flutter | 7 |
| Arrhythmias, Cardiac | 6 |
| Stroke | 6 |
| Coronary Artery Disease | 3 |
| Heart Failure | 3 |
| Hemorrhage | 2 |
| Inflammation | 2 |
| Ischemic Stroke | 2 |
| Obesity | 2 |
Trials
Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.